Progress 2022: A Preview

Back in person for the first time since 2019, Progress 2022: Learning Together in the 21st Century is stressing the “Together” in its title. On Thursday, October 27, and Friday, October 28, at the Hyatt Regency in nearby Coralville, this four-decade-old conference will show that it is still innovating and still providing attendees the most recent updates on the most critical topics in medicine. [See previous years’ coverage here.]

All early registrants pay a reduced registration fee. University of Iowa and UI-affiliated physicians, pharmacists, students, residents, and fellows also receive a discounted rate: Register here.

Below are descriptions of the objectives of the large-group plenary sessions on each day and some other key features that will take place during the two-day event.


Thursday, October 27, 2022

A Modern Approach to Clinician Safety and Well-being
8:15AM – 9:15AM
Gerard Clancy, MD

Objectives:
• Discuss the impact of the pandemic on society’s mental health and destructive behaviors
• Recognize the impact of the pandemic and society’s response on clinicians’ safety and well-being
• Apply new knowledge to assist in the building of improved systems for clinician safety and well-being


Reproductive Health in Rheumatic Diseases
9:15AM – 10:00AM
Brittany Bettendorf, MD

Objectives:
• Discuss the unique safety issues of different forms of contraception in patients with rheumatic disease
• Explain the importance of pre-pregnancy risk assessment in patients with  rheumatic disease
• Describe unique disease-specific features in pregnant women with rheumatic disease
• Discuss the safety of rheumatology medications in pregnancy and lactation


Shared Care of Oncology Patients: Managing the Mayhem of Oral Oncolytic Agents
10:15AM – 11:00AM
Susan Fajardo, PharmD

Objectives:
• Describe the mechanism of action of the groups of oral oncolytic agents discussed
• Identify common side effects associated with the agents discussed
• Design supportive care plans to effectively manage adverse effects of the agents discussed


GLP-1 Receptor Agonists and Obesity: What Are You Weighting For?
11:00AM – 11:45AM
Leon Jons, MD
Tracy Weber, PharmD RPh

Objectives:
• Discuss pharmacology of GLP-1 receptor agonists
• Describe the role of GLP-1 receptor agonists in treatment of obesity
• Identify candidates for GLP-1 receptor agonists in patients with obesity
• Create a care plan for a patient with obesity that includes a GLP-1 receptor agonist as appropriate therapy


Before the afternoon workshops, which will give attendees a choice between hot topics in food allergies or critical care, the Iowa Chapter of the Society of Hospital Medicine (SHM) will host its annual poster session at noon on Thursday. In years past, more than a couple dozen posters faced off with the winner receiving a cash prize and registration fees covered to the next national SHM meeting. To participate, see the submission guidelines here and submit your abstract here before 5 pm, on Friday, October 10. [See coverage of the last in-person poster session and chapter meeting here.]

In years past, the Iowa Chapter of the American College of Physicians held their annual meeting after the first day of Progress. At that meeting, residents from four different residency programs in the state faced off in the ACP Clinical Vignettes competition and in the Jeopardy-style quiz bowl Doctor’s Dilemma. This year, Progress organizers have added both into the first day’s schedule.

[The UI Internal Medicine Residency Program will choose its finalists for the Clinical Vignette competition next week on Wednesday afternoon, September 21.]


Friday October 28, 2022

Quality Improvement in Health Care: The Pipeline is the Process
8:15AM – 9:15AM
Kierstin Cates Kennedy, MD, MSHA FACP SFHM

Objectives:
• Describe the role of professional development in driving improvement
• Discuss the PERMA (Positive Emotions, Engagement, Relationships, Meaning, Accomplishment) model and how to apply it to developing health care professionals


Changing Landscape of Metastatic Non-Small Cell Lung Cancer (NSCLC)
9:15AM – 10:00AM
Muhammad Furqan, MD
Objectives:
• Discuss the efficacy and impact of immunotherapy in the management of Metastatic Non-Small Cell Lung Cancer (NSCLC)
• Discuss the actionable and driver molecular alterations in NSCLC
• Compare efficacy of targeted therapy to conventional therapy in NSCLC


Managing Inpatients with Hypertriglyceridemia and Insulin Protocols

10:15AM – 10:45AM
Marcelo Correia, MD PhD
Sarah C Nolan, PA-C
Objectives:
• Discuss the etiology and pathophysiology of hypertriglyceridemia
• Describe the complications of hypertriglyceridemia in hospitalized patients
• Discuss the management of hypertriglyceridemia in hospitalized patients


Monoclonal Antibodies for the Prevention and Treatment of COVID-19
10:45AM – 11:45AM
Emily B Walsh, PharmD, BCACP

Objectives:
• Describe currently available antibody products and their place in therapy in the treatment and prevention of COVID-19
• Discuss the use of monoclonal antibody therapy in the treatment of COVID-19


Day Two of Progress will offer plenaries in the above and use the afternoon for workshops and break-out sessions with updates on a variety of topics including:

  • Continuous glucose monitors
  • Chronic pain management
  • CAR-T cell therapies
  • Vaccines and vaccine schedules

This year’s Progress will be one for the record books. Don’t delay, register today!

Leave a Reply